Anatara is developing proprietary formulations for gastrointestinal health.

Introducing Gastrointestinal ReProgramming (GaRP), a microbiome-targeted complementary medicine.

Anatara’s GaRP product is a microbiome-targeted multi-component complementary medicine that has been designed to address the primary underlying factors associated with gastrointestinal disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).

Our formulations are being positioned as adjuncts to existing therapies, and will not be replacing current prescription medications. Over the last 20 years the use of complementary medicine as adjuncts to prescription drugs has increased significantly.

Non-antibiotic products for pigs and poultry.

Anatara developed Detach® for the control of scour (diarrhoea) in pigs which was approved the Australian Pesticides and Veterinary Medicines Authority (APVMA) for this application.

Detach® has been shown to reduce post-weaning diarrhoea and provide similar protection to antimicrobial agents including zinc oxide as well as reduce antimicrobial resistance However, Detach® requires labour and effort to deliver the compound by drenching. BONIFF is a revised formulation that is applied to dry feed for piglets after weaning, reducing labour input and simplifying the entire process. Anatara successfully completed a piglet challenge trial which concluded that BONIFF could be considered as a replacement for a non-physiological level of zinc oxide with commercial levels of additives in a semi-moist extruded creep piglet diet.

Anatara has also developed ANR-pf, a proprietary enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method on-farm even when stock illness is a concern. Anatara successfully completed a poultry challenge trial “Efficacy of ANR-pf on the performance of broilers subject to subclinical and necrotic enteritis challenges”.